Department of Biochemistry & Molecular Pharmacology

The Department of Biochemistry and Molecular Pharmacology at NYU Langone Health has a rich and distinguished history and maintains active research programs in epigenetics, genome integrity, protein degradation, cell cycle control, drug design, and cancer biology.
Research interests in the department include single-molecule and crystallographic investigations of protein macromolecules, analysis of the molecular basis of cell division, and the elucidation of the cellular signaling pathways involved in growth control and DNA repair. In the following videos, faculty members in the Department of Biochemistry and Molecular Pharmacology highlight the innovative research taking place in their labs.
Our faculty have received an average of $22.5 million in funding each year for the past 5 years. This funding comes from an array of federal and private sources, including the National Institutes of Health, the Howard Hughes Medical Institute, the American Cancer Society, the U.S. Department of Defense, and the New York State Department of Health.
We invite you to learn more about our faculty, educational programs, and events.
Cytoskeletal Association of ATP Citrate Lyase Controls the Mechanodynamics of Macropinocytosis
Read More
CDT1, A Licensing Factor that Limits Rereplication
Read More
Variant SARS-CoV-2 Spike Proteins Induce ACE2-Independent Membrane Interactions
Read More
Faculty

Education

Events

Related News

Researchers Reveal Newfound DNA Repair Mechanism

Surprising Insights into the Role of Oxygen in Cancer Cells

New AI Tool Makes Speedy Gene Editing Possible

Study Shows How Many Americans Have VEXAS Syndrome

Grant Supports Early Melanoma Metastasis Research

New Method Kills Cancer Cells Resistant to a KRAS Inhibitor

New Technology Overcomes Limits of Two Major Drug Classes

Cell Biologist Speaks at Pancreatic Cancer Conference

Norovirus Link to Crohn’s Disease May Point to New Therapies

How Aerobic Exercise Can Help Fight Pancreatic Cancer

Making Bacteria More Vulnerable to Common Antibiotics
